MedPath

Decision-making After Sleep Restriction

Not Applicable
Completed
Conditions
Sleep Restriction
Interventions
Behavioral: Sleep restriction
Other: Acoustic stimulation
Registration Number
NCT03692962
Lead Sponsor
Christian Baumann
Brief Summary

The aim of this project is to investigate whether enhancing sleep intensity locally in the prefrontal cortex (PFC) can counteract a deterioration of cognitive control and therefore the previously described increase in risk seeking during chronic sleep restriction. To this end, a controlled, counter-balanced study, consisting of two weeks of sleep restriction will be performed. During one of the sleep restriction weeks, sleep intensity in the PFC will be non-invasively enhanced by acoustic stimulation of slow waves during sleep.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
28
Inclusion Criteria
  • Age between 18-21 years or 26-30 years,
  • Right-handedness,
  • Good general health,
  • Good understanding of German language (as all information is provided in German)
  • Signed Informed Consent after being informed.
Exclusion Criteria
  • Contraindications on ethical grounds,
  • Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc),
  • Known or suspected non-compliance, drug or alcohol abuse (> 5dl wine/ >1l beer daily),
  • Regular medication intake,
  • Enrolment into a clinical trial within last 4 weeks,
  • Diseases or lesions of the nervous system (acute or residual included neurological and psychiatric diseases),
  • Sleep disorders (e.g. Insomnia, sleep apnoea, restless leg syndrome, narcolepsy, etc.),
  • Sleep complaints in general or excessive daytime sleepiness (Pittsburgh Sleep Quality Index > 5; Epworth Sleepiness Scale ≥ 11),
  • Irregular sleep-wake rhythm (e.g. shift working),
  • Long (> 10 hours per night) or short sleepers (< 7 hours per night),
  • Sleep efficiency < 80% in screening night,
  • Travelling with time lag less than 1 month ago (or planning to do so within 1 month prior to or during the study),
  • > 5 drinks or food items containing caffeine per day,
  • > 5 cigarettes per day,
  • Body Mass Index < 19 or > 30 kg/m2,
  • Skin allergy or very sensitive skin
  • Student of one of the following subjects: Mathematics, Physics, Computer Science, Economics, or Psychology (since students of these subjects have profound knowledge of probability calculations, which could interfere with our measurements in decision-making).
  • Red-Green Colour-Blindness (as the Risk Task requires the distinction between red and green),
  • History of claustrophobia,
  • Known hearing disorder (as acoustic stimuli will be applied during sleep),
  • Magnetic Resonance (MR) contraindication (such as pacemaker, implanted pumps, shrapnel, etc.; full MR Screening form will be filled out).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sleep restriction without acoustic stimulationSleep restriction-
Sleep restriction with acoustic stimulationSleep restriction-
Sleep restriction with acoustic stimulationAcoustic stimulation-
Primary Outcome Measures
NameTimeMethod
risk-premiumcomparison of change from baseline after 7 nights of sleep restriction with acoustic stimulation to change from baseline after 7 nights of sleep restriction without acoustic stimulation

risk-preference (i.e. risk premium assessed with the risk Task as described in Maric et al. 2017 Ann Neurol) after chronic sleep restriction with and without acoustic Stimulation will be quantified by the risk-premium derived from the choices made in the risk-task as described in Maric et al. 2017 Ann Neurol.

Secondary Outcome Measures
NameTimeMethod
confidencebefore to after 7 nights of sleep restriction with and without acoustic stimulation

overconfidence measured by an incentivised procedure that elicits the certainity equivalent of a bet based on Performance in a quiz (cf. Murad et al. 2016 J Risk Uncertain)

brain metabolitesbefore to after 7 nights of sleep restriction with and without acoustic stimulation

Glutamate and gamma-aminobutyric acid (GABA) concentration in the right prefrontal Cortex assessed by magnetic resonance (MR) spectroscopy

impulsivitybefore to after 7 nights of sleep restriction with and without acoustic stimulation

impulsivity as measured by an intertemporal choice Task.

high-density electroencephalography (hdEEG) marker of sleep pressureassessed during first and last sleep restriction nights in comparison to baseline values

Slow wave activity (SWA) assessed by hd-EEG with 128 electrodes

Effort in inhibitory control performancebefore to after 7 nights of sleep restriction with and without acoustic stimulation

Pupil response (i.e. dilation) during a simple Go/No-Go Task.

vigilance measuresbefore to after 7 nights of sleep restriction with and without acoustic stimulation

Performance impairments in the psychomotor-vigilance task

overconfidencebefore to after 7 nights of sleep restriction with and without acoustic stimulation

overconfidence measured by an incentivised procedure that elicits the certainity equivalent of a bet based on Performance in a quiz (cf. Murad et al. 2016 J Risk Uncertain)

Ocular inhibitory control performancebefore to after 7 nights of sleep restriction with and without acoustic stimulation

Ocular inhibitory control Performance measured by the Anti-Saccade Task.

Excessive daytime sleepinessbefore to after 7 nights of sleep restriction with and without acoustic stimulation

Excessive daytime sleepiness assessed by the Epworth sleepiness scale and the Stanford Sleepiness Scale.

deception willingnessbefore to after 7 nights of sleep restriction with and without acoustic stimulation

deception willingness measured by the willingness to deception of outcome in a card game with binary outcome (win and loss)

Motor inhibitory control performancebefore to after 7 nights of sleep restriction with and without acoustic stimulation

inhibitory control performance measured by the stop-signal-task.

Trial Locations

Locations (1)

University Hospital Zurich

🇨🇭

Zürich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath